An award-winning cannabis podcast for women, by women. Hear joyful stories and useful advice about cannabis for health, well-being, and fun—especially for needs specific to women like stress, sleep, and sex. We cover everything from: What’s the best weed for sex? Can I use CBD for menstrual cramps? What are the effects of the Harlequin strain or Gelato strain? And, why do we prefer to call it “cannabis” instead of “marijuana”? We also hear from you: your first time buying legal weed, and how ...
…
continue reading
Player FM - Internet Radio Done Right
Checked 2d ago
추가했습니다 nine 년 전
The Immune-Mediated Inflammatory Disease Forum에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Immune-Mediated Inflammatory Disease Forum 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
들어볼 가치가 있는 팟캐스트
스폰서 후원
<
<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/american-criminal">American Criminal</a></span>


From Airship, the studio behind American Scandal, American History Tellers, and History Daily, comes a true crime history podcast that takes you inside the minds of some of our most notorious felons and outlaws, exploring the dark side to the American dream. Host Jeremy Schwartz will introduce you to the picture-perfect brothers who teamed up to kill their parents; the thief who stole babies and ruined countless lives; the crypto king who siphoned off billions in the name of saving the world—and plenty more. From assassins and gangsters, to killers and con artists, whatever the case, whoever the criminal, you don’t know the full story—until now. Listen wherever you get your podcasts, or to get early, ad-free access to the entire season first, plus hundreds of other ad-free history podcast episodes, subscribe at IntoHistory.com.
The IMID Forum
모두 재생(하지 않음)으로 표시
Manage series 1044916
The Immune-Mediated Inflammatory Disease Forum에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Immune-Mediated Inflammatory Disease Forum 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
341 에피소드
모두 재생(하지 않음)으로 표시
Manage series 1044916
The Immune-Mediated Inflammatory Disease Forum에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Immune-Mediated Inflammatory Disease Forum 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
341 에피소드
Todos los episodios
×T
The IMID Forum

1 Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis 11:17
11:17
나중에 재생
나중에 재생
리스트
좋아요
좋아요11:17
Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers: baricitinib dose reduction in patients with RA achieving sustained disease control and switching to bDMARDs vs cycling among JAKis in patients with RA who are inadequate responders to JAKis.…
T
The IMID Forum

1 Discussing axSpA: Long-term safety and efficacy of Bimekizumab results from BE-AGILE & BE-MOBILE 1/2 25:05
25:05
나중에 재생
나중에 재생
리스트
좋아요
좋아요25:05
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in axSpA. In this episode, our faculty discusses two papers both focusing on the long-term safety and efficacy of Bimekizumab in axSpA patients with 5-year results from the BE-AGILE study and its OLE, and the 2-year results from BE-MOBILE 1 and 2.…
T
The IMID Forum

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Denis McGonagle, Professor of investigative rheumatology at the NIHR funded Academic Unit for the Musculoskeletal Diseases and Leeds Teaching Hospitals NHS Trust in the UK, as they discuss his recent review ‘Subclinical psoriatic arthritis and disease interception—where are we in 2024?’…
T
The IMID Forum

1 Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy 11:18
11:18
나중에 재생
나중에 재생
리스트
좋아요
좋아요11:18
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic diseases.…
T
The IMID Forum

1 Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib 18:42
18:42
나중에 재생
나중에 재생
리스트
좋아요
좋아요18:42
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.…
T
The IMID Forum

1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 24:13
24:13
나중에 재생
나중에 재생
리스트
좋아요
좋아요24:13
Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum

1 PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses 30:53
30:53
나중에 재생
나중에 재생
리스트
좋아요
좋아요30:53
Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc analysis examining the rapid and sustained efficacy of bimekizumab in PsA patients across different subgroups, focusing on improvements in pain, fatigue, and physical function over 16 weeks. The conversation also covered a long-term analysis of guselkumab assessing the durability of clinical improvements in joint and skin symptoms in PsA patients over a 2-year period.…
T
The IMID Forum

1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 19:16
19:16
나중에 재생
나중에 재생
리스트
좋아요
좋아요19:16
Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
T
The IMID Forum

1 Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases 26:39
26:39
나중에 재생
나중에 재생
리스트
좋아요
좋아요26:39
Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases”. Listen to them discuss key highlights from the webinar including the development of CAR T-cell therapy, the application of CAR T to autoimmune diseases, and the potential risks and reservations associated with this therapeutic approach.…
ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 1 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum

Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, and Atul Deodhar to discuss a recent study on the efficacy and safety of IV secukinumab in patient with active axSpA.
T
The IMID Forum

1 Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy 22:03
22:03
나중에 재생
나중에 재생
리스트
좋아요
좋아요22:03
Join Professor Iain McInnes and Professor Leonard Calabrese for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the efficacy and safety of JAK inhibitors and TNF inhibitors for rheumatoid arthritis, while also uncovering the best treatment strategies for difficult-to-treat RA.…
T
The IMID Forum

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Derin Karacabeyli of Arthritis Research Canada, a rheumatologist and resident in the University of British Columbia Clinician Investigator Program, as they discuss his recent paper ‘Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study’, published in PLoS One on 08th August 2024.…
T
The IMID Forum

1 Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases 32:56
32:56
나중에 재생
나중에 재생
리스트
좋아요
좋아요32:56
Webinar Highlights Podcast: Join Professor Christopher Ritchlin, and Professor Philip Mease as they discuss the recent webinar hosted on the IMID Forum ‘Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar - Part 2’. Watch them discuss key highlights from the webinar including the burden of PsA and PsO, the similarities and differences in pathology in skin and joints across psoriatic arthritis, and a special focus on IL-23, and its clinical data and impact across different tissue domains.…
T
The IMID Forum

1 PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA 21:04
21:04
나중에 재생
나중에 재생
리스트
좋아요
좋아요21:04
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered a matching-adjusted indirect comparison (MAIC) to assess the comparative efficacy of bimekizumab and risankizumab in patients with psoriatic arthritis over 52 weeks, and a post hoc analysis investigating the efficacy and safety of bimekizumab in PsA patients with or without concomitant methotrexate over 52 weeks.…
T
The IMID Forum

1 Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials 19:24
19:24
나중에 재생
나중에 재생
리스트
좋아요
좋아요19:24
Join Professor Iain McInnes and Professors Hideto Kameda and Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the long-term efficacy and safety of upadacitinib in the SELECT trials.…
T
The IMID Forum

1 Discussing AxSpA: Incidence of uveitis following bimekizumab treatment 24:11
24:11
나중에 재생
나중에 재생
리스트
좋아요
좋아요24:11
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenofon Baraliakos to discuss a recent study on the incidence of uveitis in patients with axSpA that were treated with bimekizumab.…
T
The IMID Forum

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Laura Andreoli, a Professor of Rheumatology at the University of Brescia, as they discuss her recent paper ‘The outcomes of children born to mothers with autoimmune rheumatic diseases’, published in The Lancet. Rheumatology on 11th June 2024.…
T
The IMID Forum

1 Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib 16:05
16:05
나중에 재생
나중에 재생
리스트
좋아요
좋아요16:05
Join Professor Iain McInnes and Professors Hideto Kameda and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss a paper that investigated whether the baseline neutrophil-to-lymphocyte ratio had an effect on the treatment response to filgotinib.…
T
The IMID Forum

1 Discussing PsA: Guselkumab and analysis of genetic markers 25:46
25:46
나중에 재생
나중에 재생
리스트
좋아요
좋아요25:46
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered the post hoc analysis of PsA patients receiving guselkumab, focusing on disease control across domains and patient characteristics, and a systematic review and meta-analysis on genetic markers and their response to biologics in inflammatory diseases.…
T
The IMID Forum

1 Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status 22:14
22:14
나중에 재생
나중에 재생
리스트
좋아요
좋아요22:14
Join us for the latest axSpA podcast brought to you by the Immune- ediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the results of a Phase 3 trial on upadacitinib in nr-axSpA and the clinical outcomes of certolizumab pegol treatment in nr-axSpA stratified by baseline MRI and CRP status.…
T
The IMID Forum

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the latest in bimekizumab therapy in PsA.
T
The IMID Forum

Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry’.…
T
The IMID Forum

1 Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab 29:48
29:48
나중에 재생
나중에 재생
리스트
좋아요
좋아요29:48
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the long-term etanercept response in patients with radiographic axSpA and the comparison of tofacitinib and adalimumab in a real-world clinical context.…
T
The IMID Forum

1 Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib 28:33
28:33
나중에 재생
나중에 재생
리스트
좋아요
좋아요28:33
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.
T
The IMID Forum

1 Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs 33:01
33:01
나중에 재생
나중에 재생
리스트
좋아요
좋아요33:01
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Atul Deodhar to discuss the retention rate of secukinumab over two different time periods. Our faculty then move on to discuss another publication, which compares the improvements is sacroiliac joint symptoms across patients with AS and axSpA treated with different DMARDs.…
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.